Sign in Subscribe
Pediatrics

New Algorithm for Treating Atopic Dermatitis in Pediatric Patients Released

Strategic Insights

— 1 min read

Researchers from the University Medical Centre Hamburg-Eppendorf (UKE) have developed a new algorithm for treating mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe. The algorithm focuses on topical calcineurin inhibitors as a TCS-sparing treatment strategy. This approach is intended to aid physicians in managing AD in children, particularly in sensitive skin areas.

Key Takeaways:

  • The new algorithm is designed to provide a supplementary tool to current international and national evidence-based treatment guidelines for AD in pediatric patients.
  • The algorithm recommends topical calcineurin inhibitors as a first-line treatment for mild-to-moderate AD in infants and children, including those with sensitive skin areas.
  • This approach is intended to reduce the reliance on topical corticosteroids (TCS), which have long-term utility and associated side effects.
  • The algorithm was developed through a collaboration between an international panel of six European dermatologists and pediatric specialists.
  • Current guidelines recommend TCS as a first-line treatment for short-term AD flares, but this approach is being revised due to the need for alternative treatments.

Statistics:

  • The new algorithm is intended to aid physicians who see and treat around 22 million children with AD in Europe (Source: European Dermatology Forum).
  • The use of topical calcineurin inhibitors as a first-line treatment is expected to reduce the reliance on TCS, which can have side effects such as skin thinning and suppression of the immune system.
  • The algorithm is a result of a comprehensive review of published literature and clinical experience, involving an international panel of experts.

Sources:

  • NewsRx. University Medical Centre Hamburg-Eppendorf (UKE) Researchers Release New Data on Atopic Dermatitis [A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations]. Health & Medicine Week. 2025; p 7886.
  • Journal of Dermatological Treatment. A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations. 2025, 36(1).

Read more